YourEra vs IVIM Health: Cost, Protocols, and Outcomes Compared
Quick verdict: YourEra is focused on lower entry pricing with flat dose pricing and bundled services, while IVIM Health emphasizes third-party ratings, a clinician-led GLP-1 ID protocol, and a free consult. This comparison helps you weigh cost structure, clinical protocol, third-party validation, and product type in the YourEra vs IVIM Health decision.
How these two providers differ at a glance
Both YourEra and IVIM Health are telehealth platforms prescribing compounded GLP-1 medications and both note that compounded drugs are not FDA-approved finished products. Key differences supported by the sources are upfront price and plan structure, the presence of a proprietary clinical protocol and third-party ratings, membership or program fees, and evidence or study claims. The rest of this article compares those differences directly.
Price structure and minimum commitments
YourEra advertises compounded semaglutide starting at $99/month and compounded tirzepatide from $199/month on a 6-month plan, with the lowest advertised rates reflecting that 6-month commitment. YourEra says the plan bundles consult, prescription, cold shipping, dose adjustments, and 24/7 support and that the price stays the same at every dose.
IVIM Health lists semaglutide at $75/month and tirzepatide at $133/month on its landing page but also references an ongoing rate of $174/month after an initial period and notes a $74.99/month program fee in some materials. IVIM also promotes a limited offer code for a free month membership and a no-obligation free consultation valued at $75 for new patients.
Get IVIM Health free consult and offer
Clinical protocol, monitoring, and support
YourEra positions itself as doctor-guided telehealth with licensed US clinicians reviewing intake and prescribing only when treatment is appropriate. It advertises bundled dose adjustments and 24/7 support and says prescriptions are issued only if a licensed clinician determines treatment is appropriate after evaluation.
IVIM Health emphasizes a clinician-guided GLP-1 ID protocol that it says can accelerate weight loss by up to 40% compared to a referenced standard GLP-1 protocol. The 40% figure is presented as IVIM’s proprietary claim and not an independent head-to-head trial. IVIM also highlights weekly dose adjustments and structured optimization under clinician supervision.
Third-party validation and evidence
YourEra notes LegitScript certification and licensed US clinicians but does not present third-party consumer rating scores in the supplied evidence. IVIM Health highlights a 4.9-star rating on both Google and Trustpilot and cites internal and published retrospective observational studies in Obesity Pillars related to outcomes across branded and compounded formulations, with the supplier noting these are not randomized controlled trials.
Product type and regulatory notes
Both providers dispense compounded semaglutide and compounded tirzepatide and explicitly state that compounded medications are not FDA-approved finished products and have not undergone FDA review for safety, effectiveness, or quality. Both platforms require a clinician evaluation and note that prescriptions are subject to clinician review and are not guaranteed.
Direct comparison table
| Criteria | YourEra | IVIM Health |
|---|---|---|
| Starting price (semaglutide) | Compounded from $99/mo on 6-month plan | Listed at $75/mo; published ongoing $174/mo |
| Tirzepatide pricing | Compounded from $199/mo on 6-month plan | Compounded at $133/mo; program fee noted $74.99/mo |
| Plan commitment | Lowest rates require 6-month commitment | Free month membership code available; ongoing rate higher |
| Protocol and titration | Doctor-guided with dose adjustments and 24/7 support | Proprietary GLP-1 ID protocol claiming up to 40% faster outcomes |
| Third-party ratings and evidence | LegitScript certified; licensed US clinicians | 4.9 stars on Google and Trustpilot; published retrospective studies |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
Costs versus value: unpacking what you pay for
YourEra’s value proposition is flat pricing at every dose with bundled services and free 1 to 2 day shipping from licensed US pharmacies, explicitly noting the lowest rates reflect a 6-month plan and that compounded products are not FDA-approved. IVIM lowers initial barriers with a no-obligation free consultation and a free month membership code but signals higher ongoing pricing and an additional program fee in some published materials.
Safety, eligibility, and prescriber discretion
Both sites state that prescriptions are issued only after clinician evaluation and that individual results vary. Both providers repeat the regulatory caution that compounded drugs are not FDA-reviewed finished products and therefore carry different regulatory considerations than brand-name, FDA-approved medications. Neither source provides guaranteed outcomes or universal eligibility.
YourEra vs IVIM Health: final guidance
In the YourEra vs IVIM Health choice, pick based only on the documented differences and your priorities. Choose YourEra if lower advertised entry pricing on a 6-month plan, flat dose pricing, bundled consult and ongoing support, and fast free shipping from licensed US pharmacies matter most. Choose IVIM Health if third-party review scores, a no-obligation free consultation, a free month membership code, and a clinician-led GLP-1 ID protocol with published retrospective studies are more important.